Clinical Trial

A Study to Assess the Effect Probiotic Supplement on Immune Health in Teachers Prone to Upper Respiratory Tract Infection

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 24, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The present study is a randomized, placebo-controlled, double-blind, parallel-group clinical studydesigned to assess the effects of IP on immune health in teachers prone to URTI. Approximately 179individuals aged between 18 and 50 years will be screened. Considering a screen failure of 20%,approximately 144 individuals will be randomized in a ratio of 1:1 to receive either the active orplacebo. The study will have at least 100 completed participants i.e. 50 participants in each studyarm after accounting for a dropout/withdrawal rate of 30% at the end of the study. The interventionand follow-up duration for all the study participants will be 120 days.
Trial Details
NCT Number NCT07033754
Lead Sponsor Vedic Lifesciences Pvt. Ltd.
Conditions URTI - Viral Upper Respiratory Tract Infection
Enrollment 100 participants
Start Date 2025-06-25
Primary Completion 2025-12-30 (estimated)
Study Completion 2026-01-20 (estimated)
Updated on ClinicalTrials.gov 2025-06-24